Primary Site >> Stomach Cancer
Gene >> RASSF1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. PMID: 11585730 |
Ref: Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. PMID: 11891177 Ref: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. PMID: 12448005 |
Ref: Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. PMID: 12647816 Ref: Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. PMID: 12692837 Ref: Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. PMID: 12695555 Ref: Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. PMID: 12746473 Ref: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. PMID: 14507661 |
Ref: Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. PMID: 14702190 |
Ref: The tumor suppressor RASSF1A in human carcinogenesis: an update. PMID: 15736067 Ref: Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. PMID: 16007118 Ref: Relationship between the extent of chromosomal losses and the pattern of CpG methylation in gastric carcinomas. PMID: 16224153 Ref: RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. PMID: 16265349 |
Ref: Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. PMID: 16482617 Ref: Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma. PMID: 16805821 Ref: [The influence of promoter methylation of RASSF1A on RASSF1A mRNA and protein expression in gastric cancer tissues]. PMID: 17327001 |
Ref: Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. PMID: 17376510 Ref: Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China. PMID: 17608924 |
Ref: Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB. PMID: 18203293 Ref: Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901. PMID: 18322962 |
Ref: DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells. PMID: 19037991 Ref: [5-Aza-CdR regulates the expression of RASSF1A gene in human gastric cancer cell line and inhibits the growth of cells]. PMID: 19145506 Ref: Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. PMID: 19695681 |
Ref: Hypermethylation of tumor-related genes in Tunisian patients with gastric carcinoma: clinical and biological significance. PMID: 21308683 Ref: Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). PMID: 21831520 |
Ref: Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. PMID: 22285775 Ref: Galectin-1 is up-regulated by RASSF1A gene in human gastric carcinoma cell line SGC7901. PMID: 22716213 Ref: Promoter methylation of tumor-related genes in gastric carcinogenesis. PMID: 22936446 |
Ref: 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway. PMID: 24008339 Ref: Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer. PMID: 24513424 Ref: [The systems of molecular genetic markers under cancer of stomach]. PMID: 24640104 |
Ref: Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. PMID: 23982879 Ref: Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer. PMID: 24505629 Ref: [Promoter region methylation of DNA damage repair genes in human gastric cancer]. PMID: 25331470 |
Ref: Predictive value of CHFR and MLH1 methylation in human gastric cancer. PMID: 24748501 Ref: CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis. PMID: 25483734 Ref: Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo. PMID: 26005859 Ref: Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. PMID: 26073472 |
Ref: RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expression. PMID: 26735582 Ref: Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer. PMID: 27330867 Ref: Diminished expression of MGMT & RASSF1A genes in gastric cancer in ethnic population of Kashmir. PMID: 28078123 |
Ref: Genetic Alterations in Gastric Cancer Associated with Helicobacter pylori Infection. PMID: 28512631 Ref: Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice. PMID: 29081696 Ref: Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection. PMID: 29100425 |
Ref: MicroRNA181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A. PMID: 30106448 |